April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
The Soluble Notch Ligand Dll4 Restricts Choroidal Neovascularisation by Inhibiting Endothelial Cell Proliferation
Author Affiliations & Notes
  • S. Camelo
    Centre de recherche des Cordeliers, UMRS 872, Equipe 21 P5, P6, INSERM, Paris, France
  • S. Lavalette
    Centre de recherche des Cordeliers, UMRS 872, Equipe 21 P5, P6, INSERM, Paris, France
  • W. Raoul
    Centre de recherche des Cordeliers, UMRS 872, Equipe 21 P5, P6, INSERM, Paris, France
  • M. Houssier
    Centre de recherche des Cordeliers, UMRS 872, Equipe 21 P5, P6, INSERM, Paris, France
  • C. Klein
    Centre de recherche des Cordeliers, UMRS 872, CRC-PFR-SC, P5, P6 INSERM, Paris, France
  • F. Sennlaub
    Centre de recherche des Cordeliers, UMRS 872, Equipe 21 P5, P6, INSERM, Paris, France
  • Footnotes
    Commercial Relationships  S. Camelo, None; S. Lavalette, None; W. Raoul, None; M. Houssier, None; C. Klein, None; F. Sennlaub, None.
  • Footnotes
    Support  ERCStG210345, ANR:APV05061DSA
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 6192. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S. Camelo, S. Lavalette, W. Raoul, M. Houssier, C. Klein, F. Sennlaub; The Soluble Notch Ligand Dll4 Restricts Choroidal Neovascularisation by Inhibiting Endothelial Cell Proliferation. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6192.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The Notch signaling pathway regulates pathological angiogenesis and inflammation. DLL4 interaction with Notch-1 and 4 inhibits vascular endothelial cell proliferation and DLL4 activates macrophages via Notch-1. Vascular endothelial cells and macrophages are the main players in laser induced choroidal neovascularization (CNV) in age related macular degeneration (AMD). We studied Notch expression in murine and human eyes and analyzed the effect of DLL4 on vascular endothelial cells, macrophages and CNV.

Methods: : Expression of Notch-1, 4, DLL4 and target genes were studied in human umbilical aortic endothelial cell (HUAEC) and macrophages in vitro and normal and pathological human and mouse eyes (qRT-PCR, western blot analysis and immunohistochemistry). The effects of DLL4 in vitro on HUAEC and on peritoneal macrophages and in vivo on CNV in mice was analysed by immunohistochemistry and qRT-PCR.

Results: : Notch-1 is expressed on microglia and choroidal macrophages. Neurons, blood vessels, microglia and choroidal macrophages express Notch-4. In patients with wet form of AMD Notch-4 was detected in vessels in the choroid and in subretinal neovascularization. In laser induced CNV; VEGF and HES1 a target gene of the Notch signaling pathway, were overexpressed in the mouse choroid. Intravitreal injection of DLL4 reduced the area of neovascularisation 14 days following CNV. In vitro DLL4 reduced proliferation of HUAEC. In contrast, DLL4 induced pro-angiogenic genes (VEGF, and IL-1β) in macrophages in vitro and in retina and choroid in vivo (1h after laser injury).

Conclusions: : Expression of Notch-1 and 4 in blood vessels and macrophages during CNV suggests a possible role of Notch signalling in the regulation of CNV in AMD. In mice, intravitreal injection of DLL4 reduces laser induced CNV. The anti-angiogenic effect of DLL4 is likely mediated by a direct inhibitory effect on endothelial cell proliferation and not via the regulation of macrophage secretion of growth factors. Notch modulation by DLL4 might represent a promising alternative strategy to reduce ocular neovascularisation during AMD and other neovascular diseases.

Keywords: age-related macular degeneration • choroid: neovascularization • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×